How do you manage calcium channel blocker overdose with high-dose insulin therapy?

Summary

High-dose insulin therapy is indicated in calcium channel blocker (CCB) overdose when patients present with hypotension and myocardial depression. It acts as an inotrope by overcoming the metabolic "starvation" of the myocardium and is used adjunctively with vasopressors and fluid resuscitation in the ED ¹².

Agents

• Dose: Administer a bolus of 1 U/kg regular insulin IV followed immediately by an infusion starting at 0.5–1 U/kg/hr. Run a concurrent dextrose infusion (e.g., 25 g of dextrose as a 50 mL 50% bolus) to maintain euglycemia.
• When: Initiate as soon as significant CCB toxicity is recognized, particularly in the setting of refractory hypotension and signs of myocardial dysfunction.
• Monitoring: Check blood glucose and serum potassium every 30 minutes initially. Monitor hemodynamic parameters continuously for improvement in blood pressure and perfusion ¹⁵.

Caution

• Absolute contraindication: There is no specific contraindication when used for life‐threatening CCB overdose.
• Major caution: Monitor for hypoglycemia and hypokalemia—these adverse effects are common and can worsen patient status if unrecognized.
• Major interaction: High-dose insulin requires careful coordination with dextrose infusions to avoid profound hypoglycemia, and potassium levels may fall due to intracellular shift ⁴⁵.

Targets

• Goal: Achieve hemodynamic stabilization with improvement in blood pressure and cardiac output while maintaining blood glucose between 6–8 mmol/L.
• Hold/stop if: Consider tapering the insulin infusion when there is sustained clinical improvement and the patient is hemodynamically stable over several hours, with minimal vasopressor support needed.

Dosing

Population	Dose	Max	Notes
Adult	1 U/kg IV bolus followed by 0.5–1 U/kg/hr infusion; titrate up if necessary (occasionally up to 2 U/kg/hr)	Use caution with titration	Monitor blood glucose and potassium every 30 minutes; adjust dextrose infusion accordingly 15
Peds	1 U/kg IV bolus followed by 0.5–1 U/kg/hr infusion	As per weight-based limits	Similar monitoring protocol to adults; consider lower absolute volumes and more frequent checks
Pregnancy	Similar to adult dosing	Use same maximal dosing	No contraindications in pregnancy, but careful monitoring is critical due to variable maternal physiology

Adjustments

• Renal: In renal impairment, adjustments to dextrose infusion may be required, though insulin is dosed by weight without modification.
• Hepatic: No specific hepatic adjustment is typically necessary.
• Obesity: Use actual body weight for dosing; however, consider potential effects of insulin resistance in obese patients and adjust dextrose supplementation accordingly ¹.

Adverse effects to watch for

• Hypoglycemia
• Hypokalemia
• Hypomagnesemia and hypophosphatemia (secondary electrolyte shifts)

Alternatives

• Vasopressors (e.g., norepinephrine or epinephrine)—useful for more immediate hemodynamic support.
• Calcium (chloride or gluconate) and glucagon—may provide transient improvement in contractility but are less effective as sole therapies compared to high-dose insulin ¹²